GKOS (US)


May 1, 2025

GKOS: iDose & iStent Policy Landscape

By John Leppard

With GKOS shares down pre-market amid questions on its earnings call last night regarding the Medicare policy issues affecting iDose and iStent sales, we offer the following takeaways: We generally agree with the company that,…

Read More >>

January 6, 2025

Conference Policy Prep Pack: Devices, Diagnostics, & Tools

By John Leppard

With medical device, equipment, diagnostics, and life science tools (LST) companies set to descend on San Francisco next week for a key investor conference, below we provide a set of significant policy-related questions for clients…

Read More >>